The Council on Peripheral Vascular Disease (PVD) seeks to integrate the academic and clinical missions of all interdisciplinary vascular health professionals in order to expand professional and public vascular education; to advance the basic science and clinical research and evidence based practice; and to thereby improve clinical outcomes of individuals with PVD.
Annually AHA asks all of its Councils and science groups what in their estimation have been the most important advances in their respective fields within the past year. We have pulled out of all of those suggestions the ones that came from or are relevant to our community. Several studies this year brought the future of medicine closer to the present with new insight into emerging technologies. These advances and their potential to impact peripheral vascular disease and the patient are listed in the table below.
Mary M. McDermott MD, FAHA,
is the Chair of the PVD Council. She is also Professor of Medicine Northwestern University Feinberg School of Medicine and Contributing Editor for JAMA.
Michael Conte, MD, FAHA,
is Vice Chair of the PVD Council. He is also Professor and Chief, University of California, San Francisco, Division of Vascular Surgery.